TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomas aeruginosa secreting type III secretory toxins

Respiratory Research

Volumn 5, Issue , 2004, Pages

  Faurer, Karine ^a   Sawa, Teiji ^b   Ajayi, Temitayo ^b,c   Fujimoto, Junichi ^d   Moriyama, Kiyoshi ^b   Shime, Nobuaki ^e   Wiener Kronish, Jeanine P ^b,c  

^a Lab de Rech en Pathol Infectieuse   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOKINE; TOLL LIKE RECEPTOR 4; BACTERIAL PROTEIN; PSEUDOMONAS EXOPROTEIN A PROTEIN, PSEUDOMONAS AERUGINOSA; TLR4 PROTEIN, MOUSE;

ACUTE LUNG INJURY; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; DISEASE SEVERITY; DRY WEIGHT; GENE MUTATION; HOST RESISTANCE; HUMAN; LUNG EDEMA; LUNG HOMOGENATE; LUNG LAVAGE; MALE; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA; SEPSIS; SURVIVAL; WILD TYPE; ACUTE DISEASE; ANIMAL; C3H MOUSE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; GRAM NEGATIVE INFECTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SURVIVAL RATE;

ACUTE DISEASE; ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C3H; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; SURVIVAL RATE; TOLL-LIKE RECEPTOR 4;

EID: 17144405602     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1465-9921-5-1     Document Type: Article

References (36)

1. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
2. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C: The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999, 159:1249-1256.
3. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995, 274:968-974.
4. Finck-Barbancon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP, Fleiszig SM, Wu C, Mende-Mueller L, Frank DW: ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 1997, 25:547-557.
5. Fleiszig SM, Wiener-Kronish JP, Miyazaki H, Vallas V, Mostov KE, Kanada D, Sawa T, Yen TS, Frank DW: Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 1997, 65:579-586.
6. Kudoh I, Wiener-Kronish JP, Hashimoto S, Pittet JF, Frank D: Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol 1994, 267:L551-556.
7. Sawa T, Ohara M, Kurahashi K, Twining SS, Frank DW, Doroques DB, Long T, Gropper MA, Wiener-Kronish JP: In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections. Infect Immun 1988, 66:3242-3249.
8. Wiener-Kronish JP, Frank DW, Sawa T: Mechanisms of lung epithelial cell injury by acute by Pseudomonas aeruginosa. In Molecular biology of acute lung injury Edited by: Clark RSB, Carcillo JA. Boston: Kluwer Academic Publishers; 2001:149-161.
9. Wiener-Kronish JP, Sakuma T, Kudoh I, Pittet JF, Frank D, Dobbs L, Vasil ML, Matthay MA: Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J Appl Physiol 1993, 75:1661-1669.
10. Galan JE, Collmer A: Type III secretion machines: bacterial devices for protein delivery into host cells. Science 1999, 284:1322-1328.
11. Hueck CJ: Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 1998, 62:379-433.
12. Barinaga M: A shared strategy for virulence. Science 1996, 272:1261-1263.
13. Lee CA: Type III secretion systems: machines to deliver bacterial proteins into eukaryotic cells? Trends Microbiol 1997, 5:148-156.
14. Mecsas J, Strauss EJ: Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands. Emerging Infect Dis 1996, 2:271-284.
15. Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, Wiener-Kronish JP: Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest 1999, 104:743-750.
16. Sawa T, Yahr TL, Ohara M, Kurahashi K, Gropper MA, Wiener-Kronish JP, Frank DW: Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 1999, 5:392-398.
17. 2 in sepsis associated with Pseudomonas aeruginosa. J Immunol 2001, 167:5880-5886.
18. Frank DW, Vallis A, Wiener-Kronish JP, Roy-Burman A, Spack EG, Mullaney BP, Megdoud M, Marks JD, Fritz R, Sawa T: Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J Infect Dis 2002, 186:64-73.
19. Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, Engel JN, Rello J: Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 2002, 30:521-528.
20. Roy-Burman A, Savel RH, Racine S, Swanson BL, Revadigar NS, Fujimoto J, Sawa T, Frank DW, Wiener-Kronish JP: Type III Protein Secretion is Associated with Death in Lower Respiratory and Systemic Pseudomonas aeruginosa infection. J Infect Dis 2001, 183:1767-1774.
21. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990, 113:227-242.
22. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999, 162:3749-752.
23. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D: Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (tlr4). J Exp Med 1999, 189:615-625.
24. Wiener-Kronish JP, Albertine KH, Matthay MA: Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest 1991, 88:864-875.
25. Beg AA: Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 2002, 23:509-512.
26. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, Kwak LW: Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 2002, 298:1025-1029.
27. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in tlr4 gene. Science 1998, 282:2085-2088.
28. Sawa T, Corry DB, Gropper MA, Ohara M, Kurahashi K, Wiener-Kronish JP: IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol 1997, 159:2858-2866.
29. Khabar KS, Siddiqui S, Armstrong JA: WEHI-13VAR: a stable and sensitive variant of WEHI 164 clone 13 fibrosarcoma for tumor necrosis factor bioassay. Immunol Lett 1995, 46:107-110.
30. Sato H, Frank DW, Hillard CJ, Feix JB, Pankhaniya RR, Moriyama K, Finck-Barbancon V, Buchaklian A, Lei M, Long RM, Wiener-Kronish J, Sawa T: The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J 2003, 22:2959-2969.
31. Geiser TK, Kazmierczak BI, Garrity-Ryan LK, Matthay MA, Engel JN: Pseudomonas aeruginosa ExoT inhibits in vitro lung epithelial wound repair. Cell Microbiol 2001, 3:223-236.
32. Rocchetta HL, Burrows LL, Lam JS: Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 1999, 63:523-553.
33. Groisman EA, Ochman H: Pathogenicity islands: bacterial evolution in quantum leaps. Cell 1996, 87:791-794.
34. Mel SF, Mekalanos JJ: Modulation of horizontal gene transfer in pathogenic bacteria by in vivo signals. Cell 1996, 87:795-798.
35. Johnson GB, Brunn GJ, Tang AH, Platt JL: Evelutionalry clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol 2003, 24:19-24.
36. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, Elbim C, Hitchcock R, Lammas D, Davies G, Al-Ghonaium A, Al-Rayes H, Al-Jumaah S, Al-Hajjar S, Al-Mohsen IZ, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkeji H, Haraguchi S, Day NK, Good RA, Gougerot-Pocidalo MA, Ozinsky A, Casanova JL: Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003, 299:2076-2079.